| __timestamp | Taro Pharmaceutical Industries Ltd. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 91733000 | 17992000000 |
| Thursday, January 1, 2015 | 87644000 | 22400000000 |
| Friday, January 1, 2016 | 92365000 | 23910000000 |
| Sunday, January 1, 2017 | 85656000 | 23813000000 |
| Monday, January 1, 2018 | 88196000 | 24694000000 |
| Tuesday, January 1, 2019 | 89971000 | 23557000000 |
| Wednesday, January 1, 2020 | 93413000 | 25436000000 |
| Friday, January 1, 2021 | 91355000 | 24586000000 |
| Saturday, January 1, 2022 | 113676000 | 27295000000 |
| Sunday, January 1, 2023 | 198366000 | 34205000000 |
| Monday, January 1, 2024 | 218935000 | 28113000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry giants: Walgreens Boots Alliance, Inc. and Taro Pharmaceutical Industries Ltd., from 2014 to 2024. Over this decade, Walgreens consistently outpaced Taro in SG&A spending, with figures peaking at approximately $28 billion in 2024, a 59% increase from 2014. In contrast, Taro's expenses grew by 138%, reaching around $219 million in 2024. This stark difference highlights Walgreens' expansive operational scale compared to Taro's more conservative approach. The data underscores the strategic choices each company makes in managing operational costs, reflecting their market positioning and growth strategies. As the industry faces new challenges, understanding these financial dynamics is crucial for stakeholders and investors alike.
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Merus N.V.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends